Results 131 to 140 of about 172,507 (213)

Causal Relationship Between Genetically Determined Free Fatty Acids and Nonalcoholic Fatty Liver Disease: A Mendelian Randomization Study. [PDF]

Int J Endocrinol
Li K, Liang Y, Zhang X, Hu P, Hu M.
europepmc   +1 more source

Letter: nonalcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density [PDF]

, 2019
Razieh Bidhendi Yarandi
openalex   +1 more source

Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease

, 2022
K. A. Andreev, Yu. P. Skirdenko, Н. А. Николаев, М. А. Ливзан, А. В. Горбенко, М. М. Федорин, Т. С. Кролевец   +6 more
openalex   +2 more sources

Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

Hepatology, 2010
H. Tilg, A. Moschen
semanticscholar   +1 more source

Managing Nonalcoholic Fatty Liver Disease Through Structured Lifestyle Modification Interventions. [PDF]

Am J Lifestyle Med
Thomas A, Thomas A.
europepmc   +1 more source

A Widespread Acquired Ailment, Nonalcoholic Fatty Liver Disease; Its Approaches Related to Nutritional Therapy

, 2021
M M Hassan, Yasir Abbas Shah, Aisha Tariq, Zainab Qasim, Sehrish Jabbar, Mushaim Fatima   +5 more
openalex   +1 more source

Major Depression as a Catalyst for Nonalcoholic Fatty Liver Disease: Insights From a Comprehensive Mendelian Randomization Study. [PDF]

Can J Gastroenterol Hepatol
Su Y, Lin S, She L, Xiong J, Ding Y, Zhang Y, Chen Y.   +6 more
europepmc   +1 more source

Association of worsening of nonalcoholic fatty liver disease with cardiometabolic function and intestinal bacterial overgrowth: A cross-sectional study

, 2020
Marília Marques Pereira Lira, José Eymard Moraes de Medeiros Filho, Vinícius José Baccin Martins, Gitana da Silva, Francisco Antônio Oliveira Júnior, Éder Jackson Bezerra de Almeida Filho, Alexandre Sérgio Silva, João Henrique Costa‐Silva, José Luiz de Brito Alves   +8 more
openalex   +1 more source

Pachymaran alleviates fat accumulation, hepatocyte degeneration, and injury in mice with nonalcoholic fatty liver disease. [PDF]

Open Med (Wars)
Yu H, Wan M, Li H, Liu X.
europepmc   +1 more source

The potential of spironolactone to mitigate the risk of nonalcoholic fatty liver disease in hypertensive populations: evidence from a cohort study

Di Shen, Shuaiwei Song, Junli Hu, Xintian Cai, Qing Zhu, Yingying Zhang, Rui Ma, Pan Zhou, Zhiqiang Zhang, Jing Hong, Nanfang Li   +10 more
openalex   +1 more source